Media Release Basel, 18 June 2019 First tumour-agnostic medicine approved in Japan for adult and paediatric patients with NTRK fusion-positive advanced recurrent solid tumours Approval supported by the data mainly from the pivotal Phase II STARTRK-2 study showing that Rozlytrek shrank tumours in more than half of people with NTRK fusion-positive solid tumours, across 10Details
Author: Sarah Beauchamp From the Trump administration’s “America First” agenda to new medical meeting regulations, a number of issues are being blamed for keeping international doctors from attending medical meetings in the United States. At the same time, the decrease in international travel to the U.S. overall may have begun to spill into the eventsDetails
Good news! MedTech Europe recently published an updated version of their Code of Ethical Business Practices which includes extended Q&As that specifically address PCOs and their allowances under the new code. Based on new Q&As, non-related PCOs ARE able to request “commercial agreements” from MedTech Member Companies and use funds received to then sponsor HCPsDetails
ABTS Convention Services attains Trusted Partner Certification through MedTech Europe’s Ethical Charter- First in the US.
ABTS Convention Services (ABTS), a global meetings and convention services company with 19 years of experience, has attained Ethical Charter Certification from MedTech Europe. ABTS Convention Services is the first meetings and events company in the US to be certified through the MedTech Europe Ethical Charter.Details
Meeting International Compliance- What Your Medical Meeting Needs to Know for 2018 and Beyond
Presented at HCEAConnect 2017 by:
Davide Veglia, ABTS Convention Services
Christine M. Sainvil, Ethical MedTech
Augist 13, 2017 | Chicago, IllinoisDetails
The most important change for the US Medical Meeting Industry is that MedTech Europe member companies will not be able to directly sponsor an HCP, neither as a delegate nor as a speaker. As of 2018, MedTech Europe will require all meetings to be vetted through its Conference Vetting System, only these meetings will be eligible to receive funds from MedTech Europe member companies, — and only through educational grants.
Healthcare Organizations should brace themselves for an impact and will need to plan for a loss in revenue from any international delegation sponsored by Medical Technology Companies in Europe. From the ABTS portfolio of clients, we expect about 30 percent of delegations to be at risk for 2018 unless there is an overhaul of the current process to meet the Common Code requirements.Details
It’s not even half over, but 2017 already has been marked by a range of new rules for travelers. From attempting to ban citizens of six Muslim-majority countries from entering the United States to prohibiting certain carry-on electronics on U.S.- and U.K.-bound flights, the airport experience feels dramatically different from years past.Details
Changing compliance codes in Europe regulating medical-device companies are expected to have a major effect on U.S.-based medical conferences — and to continue to do so for years to come. Specifically, any conference with a European delegation sponsored by a medical-device company will be affected by the new EthicalMedTech regulations coming into play in 2018, according to Patricia Andrade, vice president of marketing and communications at ABTS Convention Services.Details
The Executive Order signed on March 6, 2017, allows for the proper review and establishment of standards to prevent terrorist or criminal infiltration by foreign nationals. The United States has the world’s most generous immigration system, yet it has been repeatedly exploited by terrorists and other malicious actors who seek to do us harm. InDetails